US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 28.990
  • +2.810+10.73%
Close Nov 19 16:00 ET
  • 29.160
  • +0.170+0.59%
Post 16:46 ET
3.61BMarket Cap-14280P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
Operating revenue
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
Cost of revenue
49.74%33.56M
175.69%23.1M
158.79%20.21M
938.15%58.51M
580.75%19.91M
1,522.74%22.41M
10,118.29%8.38M
526.22%7.81M
8.38%5.64M
-42.09%2.93M
Gross profit
85.56%163.27M
103.93%176.59M
310.71%152.12M
384.45%338.08M
540.72%126.47M
325.58%87.99M
433.19%86.59M
181.99%37.04M
13.73%69.79M
-64.27%19.74M
Operating expense
-6.45%210.55M
-0.48%206.03M
0.98%214.21M
28.72%855.2M
14.80%210.98M
29.64%225.07M
25.58%207.03M
49.24%212.12M
11.17%664.4M
27.07%183.79M
Selling and administrative expenses
-16.25%121.98M
15.00%128.08M
26.85%129.51M
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
56.79%277.16M
103.48%84.37M
-General and administrative expense
----
----
----
80.69%500.82M
----
----
----
----
56.79%277.16M
103.48%84.37M
Research and development costs
11.52%88.57M
-18.51%77.95M
-23.02%84.7M
-8.48%354.39M
-30.32%69.28M
-16.58%79.42M
-5.90%95.66M
20.98%110.03M
-7.99%387.24M
-3.64%99.42M
Operating profit
65.51%-47.28M
75.55%-29.44M
64.54%-62.09M
13.03%-517.12M
48.48%-84.52M
10.37%-137.08M
18.96%-120.44M
-35.73%-175.08M
-10.88%-594.61M
-83.50%-164.05M
Net non-operating interest income expense
-315.47%-9.64M
-361.17%-6.18M
-71.54%-3.66M
63.53%-8.65M
9.77%-2.85M
54.44%-2.32M
80.92%-1.34M
74.69%-2.14M
-84.92%-23.71M
-6.11%-3.16M
Non-operating interest income
-42.09%2.89M
-46.95%3.18M
-38.75%3.3M
134.83%20.93M
-0.59%4.55M
77.61%4.99M
319.13%6M
5,403.06%5.39M
2,032.54%8.91M
12,264.86%4.58M
Non-operating interest expense
71.44%12.53M
27.49%9.36M
-7.46%6.97M
-9.33%29.58M
-4.34%7.4M
-7.50%7.31M
-13.10%7.34M
-11.82%7.53M
146.40%32.63M
156.39%7.74M
Other net income (expense)
111.61%70K
-2,955.56%-1.93M
-80.14%-499K
97.81%-727K
189.02%219K
98.16%-603K
-142.28%-63K
4.15%-277K
83.15%-33.18M
99.55%-246K
Special income (charges)
--0
---1.95M
----
--0
--0
--0
--0
----
67.30%-32.89M
--0
-Less:Other special charges
----
--1.95M
----
----
----
----
----
----
-67.30%32.89M
--0
Other non- operating income (expenses)
111.61%70K
138.10%24K
-80.14%-499K
-152.43%-727K
189.02%219K
-709.09%-603K
-142.28%-63K
4.15%-277K
-121.15%-288K
-6,050.00%-246K
Income before tax
59.39%-56.85M
69.19%-37.54M
62.67%-66.25M
19.19%-526.5M
47.96%-87.15M
26.63%-140M
21.64%-121.84M
-28.88%-177.5M
12.67%-651.5M
-13.47%-167.46M
Income tax
154.08%592K
-41.24%114K
-39.72%170K
218.68%2.13M
196.74%1.42M
-47.76%233K
-60.08%194K
-76.66%282K
90.06%669K
-517.90%-1.47M
Net income
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
Net income continuous Operations
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
Minority interest income
Net income attributable to the parent company
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
Basic earnings per share
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
Diluted earnings per share
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M
Operating revenue 78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M
Cost of revenue 49.74%33.56M175.69%23.1M158.79%20.21M938.15%58.51M580.75%19.91M1,522.74%22.41M10,118.29%8.38M526.22%7.81M8.38%5.64M-42.09%2.93M
Gross profit 85.56%163.27M103.93%176.59M310.71%152.12M384.45%338.08M540.72%126.47M325.58%87.99M433.19%86.59M181.99%37.04M13.73%69.79M-64.27%19.74M
Operating expense -6.45%210.55M-0.48%206.03M0.98%214.21M28.72%855.2M14.80%210.98M29.64%225.07M25.58%207.03M49.24%212.12M11.17%664.4M27.07%183.79M
Selling and administrative expenses -16.25%121.98M15.00%128.08M26.85%129.51M80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M56.79%277.16M103.48%84.37M
-General and administrative expense ------------80.69%500.82M----------------56.79%277.16M103.48%84.37M
Research and development costs 11.52%88.57M-18.51%77.95M-23.02%84.7M-8.48%354.39M-30.32%69.28M-16.58%79.42M-5.90%95.66M20.98%110.03M-7.99%387.24M-3.64%99.42M
Operating profit 65.51%-47.28M75.55%-29.44M64.54%-62.09M13.03%-517.12M48.48%-84.52M10.37%-137.08M18.96%-120.44M-35.73%-175.08M-10.88%-594.61M-83.50%-164.05M
Net non-operating interest income expense -315.47%-9.64M-361.17%-6.18M-71.54%-3.66M63.53%-8.65M9.77%-2.85M54.44%-2.32M80.92%-1.34M74.69%-2.14M-84.92%-23.71M-6.11%-3.16M
Non-operating interest income -42.09%2.89M-46.95%3.18M-38.75%3.3M134.83%20.93M-0.59%4.55M77.61%4.99M319.13%6M5,403.06%5.39M2,032.54%8.91M12,264.86%4.58M
Non-operating interest expense 71.44%12.53M27.49%9.36M-7.46%6.97M-9.33%29.58M-4.34%7.4M-7.50%7.31M-13.10%7.34M-11.82%7.53M146.40%32.63M156.39%7.74M
Other net income (expense) 111.61%70K-2,955.56%-1.93M-80.14%-499K97.81%-727K189.02%219K98.16%-603K-142.28%-63K4.15%-277K83.15%-33.18M99.55%-246K
Special income (charges) --0---1.95M------0--0--0--0----67.30%-32.89M--0
-Less:Other special charges ------1.95M-------------------------67.30%32.89M--0
Other non- operating income (expenses) 111.61%70K138.10%24K-80.14%-499K-152.43%-727K189.02%219K-709.09%-603K-142.28%-63K4.15%-277K-121.15%-288K-6,050.00%-246K
Income before tax 59.39%-56.85M69.19%-37.54M62.67%-66.25M19.19%-526.5M47.96%-87.15M26.63%-140M21.64%-121.84M-28.88%-177.5M12.67%-651.5M-13.47%-167.46M
Income tax 154.08%592K-41.24%114K-39.72%170K218.68%2.13M196.74%1.42M-47.76%233K-60.08%194K-76.66%282K90.06%669K-517.90%-1.47M
Net income 59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M
Net income continuous Operations 59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M
Minority interest income
Net income attributable to the parent company 59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M
Basic earnings per share 60.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.5
Diluted earnings per share 60.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday-2.87%